High-Dose Chemotherapy with Hematopoietic Stem-Cell Rescue for High-Risk Breast CancerSjoerd Rodenhuis, Elisabeth G.E. de Vries, John Wagstaff et al.|New England Journal of Medicine|2003Cited by 262
“Classical” CMF versus a 3-weekly intravenous CMF schedule in postmenopausal patients with advanced breast cancerE Engelsman, Richard Sylvester, L.V.A.M. Beex et al.|European Journal of Cancer and Clinical Oncology|1991Cited by 165